Group items tagged

The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with "high-risk/high-reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer. The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field. Awards are made to institutions for support of the Damon Runyon-Rachleff Innovation Investigators. All awards are approved by the Board of Directors of the Damon Runyon Cancer Research Foundation acting upon the recommendation of the Innovation Award Committee.

The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with "high-risk/high-reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer. The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field. Awards are made to institutions for support of the Damon Runyon-Rachleff Innovation Investigators. All awards are approved by the Board of Directors of the Damon Runyon Cancer Research Foundation acting upon the recommendation of the Innovation Award Committee.

The Alport Syndrome Foundation (ASF) is inviting applications for the Paul Silver Enrichment Award in memory of Paul Silver, an Alport syndrome patient. Silver was a film and music editor in Hollywood who passed away in 2004 at the age of 38. In 1985, he was a Communications major studying filmmaking at Pennsylvania State University and needed a camera to document his trip to Tuscany, Italy, where was he was planning to attend a summer study program. Silver applied for, and won, the Anthony Maimone Memorial Award and was able to make a documentary film for the university about his experiences in Italy and the benefits of the program. The purpose of the award is to "pay it forward" and help other young people affected by Alport syndrome achieve one of their goals. The award can be used to complete a project or pursue an activity that will enhance the applicant's life. The program is open to individuals between the ages of 16 and 22 affected by Alport syndrome.  The award selection committee has a total of $3,000 to award, at its discretion, to one or more applications. Applicants will be evaluated on the purpose and potential impact of the award, if the award will allow the applicant to achieve their stated goal, the quality of the essay, recommendation letters, and completeness of the submission. Applications will be accepted between September 1 and November 16, 2019, with winners to be notified in early January 2020.

1) Liver Scholar Awards: Three-year grants of up to $225,000 will be awarded in support of basic science research projects. The goal of the program is to provide young scientists with support at an early stage of their careers to bridge the gap between completion of their research training and attainment of status as an independent research scientist. While applications on all liver-related research topics will be considered, preference will be given to projects related to biliary atresia and primary biliary cirrhosis. 2) Postdoctoral Research Fellowship Award: One-year grants of up to $12,500 will be awarded to support MD, PhD, and MD/PhD postdoctoral fellows in their first or second year of appointment as a postdoctoral research fellow or trainee and who seek professional development, additional training, and experience in liver research. The foundation encourages projects related to transplantation, autoimmune hepatitis, hepatitis, primary sclerosing cholangitis, biliary atresia, and primary biliary cirrhosis. 3) Primary Biliary Cholangitis (PBC) Fund for the Cure Award: The PBC Fund for the Cure Award is a one-year award of $100,000 that provides support for a faculty member to initiate a project that addresses a novel and important research question related to the process by which primary biliary cholangitis attacks the liver. The proposed investigation may involve basic, clinical, or translational research. The award supports investigational work related but not limited to pathophysiological studies, clinical trials and applications, or assessment of new diagnostic and/or therapeutic modalities.

The Therapeutic Idea Award is designed to promote new ideas aimed at drug, treatment, and target discovery that are still in the early stages of development. Proposed research projects should include a well-formulated, testable hypothesis based on strong scientific rationale that holds translational potential to improve ALS treatment and/or advance a novel treatment modality. Projects that focus primarily on investigating the pathophysiology of ALS are outside the scope of this mechanism.New for FY15: In addition to hypothesis-based ideas aimed at drug or treatment discovery, the FY15 Therapeutic Idea Award will support the following topics, which were previously supported under the ALSRP Therapeutic Development Award mechanism. Development, validation, and application of high-throughput screens to define targets with therapeutic potential or to identify lead agent candidates for ALS treatment; Development, modification, and/or validation of preclinical model systems in order to assess lead compounds and potential therapeutics by pharmacological and/or pharmacokinetic testing. Such models would also serve as improved tools for the ALS research community.Applicants contemplating development of products beyond drug or treatment discovery should apply to the ALSRP Therapeutic Development Award, which supports advanced preclinical development activities.Innovation and impact are the most important aspects of the Therapeutic Idea Award. Applications that demonstrate exceptional scientific merit but lack innovation and highDoD FY15 ALSRP Therapeutic Idea Award 4potential impact do not meet the intent of the Therapeutic Idea Award. Presentation of preliminary data is not consistent with the intent of the Therapeutic Idea Award mechanism. While the inclusion of preliminary data is not prohibited, the strength of the application should not rely on preliminary data, but on the innovative idea and the potential impact it will provide.

The Melanoma Research Foundation is accepting applications from emerging and established scientific investigators for research projects that explore new avenues in melanoma biology, prevention and treatments, with the goal of finding a cure. The foundation makes grants in four areas: Career Development Awards, Established Investigator Awards, Career Investigator CURE OM Awards, and Established Investigator CURE OM Awards. Career Development Awards provide funding of up to $50,000 a year for two years to junior investigators who are beginning a research career emphasizing melanoma-related projects and have not yet secured strong federal funding for their research. Established Investigator Awards provide funding of up to $100,000 a year for two years to established melanoma researchers or senior researchers working in closely related fields who wish to move into melanoma research. Career Development CURE OM Awards provide funding of up to $50,000 a year for two years to junior investigators in the ocular/uveal melanoma field. Established Investigator CURE OM Awards provides funding of up to $100,000 a year for two years to established ocular/uveal melanoma researchers, or senior researchers.

The Progeria Research Foundation is seeking proposals from principal researchers for projects related to Hutchinson-Gilford Progeria Syndrome (HGPS), a rare, fatal, "premature aging" disease that affects children who die of heart disease at an average age of 13 - the same heart disease that affects millions of normal aging adults (atherosclerosis). The program supports research projects with specific relevance to HGPS and that show promise for contributing to the scientific or clinical advancement in this field of study. Grants are awarded in three categories:  Innovator Awards, Established Investigator Awards, and Specialty Awards. 1) Innovator Awards: Two-year grants of up to $75,000 a year are available  to  investigators eagerto embark on new lines of investigation and  produce enough preliminary data to be competitive for longer-term funding by NIH and/or other agencies. 2) Established Investigator Awards: Three-year grants of up to $100,000 a year are available to senior investigators established either in the field of HGPS or a field that can be directly applied to it. 3) Specialty Awards: These grants are awarded for smaller, more technology-driven projects, including sequencing, screening potential drugs, obtaining cell lines (including IPSCs), and preparation of antibodies.  Funding amounts and lengths are flexible.

Miami faculty should notify Associate Provost Jim Oris of their interest in the following RFP. ---------- CGS invites doctoral-granting member institutions to apply to participate in Understanding PhD Career Pathways for Program Improvement, a multi-institution effort to collect and use data on PhD career pathways, funded by The Andrew W. Mellon Foundation and the National Science Foundation (NSF #1661272). This is an important opportunity to deepen your institution's understanding of the career goals and outcomes of its PhDs; communicate your support for the career diversity of PhDs; make evidence-based interventions that support the success of PhDs and the recruitment of future students; and access anonymized benchmarking data compiled from other project partners.   Awards: Option 1: Humanities Only. Provides awards of $30,000 each to support implementation of surveys of humanities PhD students and alumni over a period of twenty-four months. Supported by the Andrew W. Mellon Foundation; 15 awards available. Please indicate in your proposal why a humanities-only project aligns with your institutional mission.   Option 2: STEM Only. Provides awards of $50,000 to each to support implementation of surveys of STEM PhD students and alumni over a period of thirty-six months. Supported by the National Science Foundation; 15 awards available. Please indicate in your proposal why a STEM-only project aligns with your institutional mission.   Option 3: Combined Proposal. If an institution meets the eligibility requirements for both the Humanities and STEM awards, CGS strongly encourages the submission of a combined proposal. Institutions selected to participate in this category will receive a total award amount of $80,000.

The training of a new generation of psychiatric academicians is a major objective of the Society of Biological Psychiatry.  Participation in professional meetings, where new information is exchanged and contacts are made, can have a critical impact on the career of a developing clinician-scientist. In recognition of the importance of academic exchange, the Society of Biological Psychiatry (SOBP) annually selects distinguished junior scientists to be a part of our Travel Fellowship Award program. Each travel fellowship award includes: $1,500 to help defray the travel and living cost to attend the 2014 annual meeting Waived registration to attend the 2014 meeting Waived registration to attend the 2015 and 2016 annual meeting (no financial award) An SOBP member mentor assigned to you during the meeting Opportunity to present a poster or oral abstract without an SOBP member sponsor Recognition events in honor of the Travel Fellowship Award recipeints To receive the travel award, applicants are expected to attend the entire meeting, be present for the recognition events, submit an abstract for a poster or oral presentation, and participate in the mentor/mentee program for young investigators.  These awards are supported by the Society of Biological Psychiatry and Elsevier, publisher of the Society's journal, Biological Psychiatry.

To that end, the two organizations have issued a Request for Applications for projects that test feasibility and generate preliminary data. MRA and ACS have each committed $1 million for the awards. The combined $2 million will be used to fund Multidisciplinary Team Awards and Pilot Awards. 1) Multidisciplinary Team Awards: At least one grant of up to $1 million will be awarded in this category are designed to foster interdisciplinary collaborative research to promote transformational advances with the potential for rapid clinical benefit. Letters of Intent must be received no later than August. Upon review, selected applicants will be invited to submit full applications by October 31, 2017. 2) Pilot Awards: Up to five grants of up to $200,000 each will be awarded over two years to help seed the ground in this relatively young area of checkpoint irAE research. Applications must be received no later than October 16, 2017.

The awards are open to researchers based at both national and international accredited academic and nonprofit research institutions. Funding mechanisms include: Senior Faculty Awards ($400,000 per year) - to support established investigators who are thought leaders in their fields and are recognized for substantial contributions of creative and productive research. We will seek to complement other major funders of research by placing emphasis on projects that may not be supported by traditional sources because of their perceived novelty or high risk, or because the investigator is moving into female reproductive aging from a different research area. Junior Faculty Awards ($250,000 per year) - to support newly independent investigators with outstanding promise when they are establishing their own labs and are malleable in the direction of their research. These awards will allow bright young scientists to pursue bold ideas when they are at their most scientifically creative. Pilot Awards ($100,000 per year) - to foster innovative collaborative or novel research projects that have the potential for high impact and high reward at an accelerated rate. These awards will allow collection of preliminary data to apply for larger grants. Postdoctoral Fellowships ($100,000 per year) - to increase the number of imaginative, well-trained junior scientists who will form the next generation of reproductive aging researchers. These awards will facilitate our efforts to build the field and provide both training and networking opportunities for trainees.

A. Noam Chomsky Global Connections Awards celebrate the power of human connections. The awards recognize distinguished service to the global mission of the STAR Scholars Network. Several individuals with a deep impact on advancing global, social mobility are recognized every year. We live in a time when innovation and creativity in support of humanity are of great importance. The Star Scholars Network recognizes the commitment of concerned people able and willing to make a difference in the lives of others. Nominations for this award are solicited from around the world. The nominee can be from any field. Beginning in 2020, the Star Scholars Network is committed to promoting transnational research, or collaborative research between scholars of two or more countries (e.g., joint publications, research partnerships, etc.). The Global Connections Awards recognize STAR Scholars for their achievements and distinctive contributions to translational research that demonstrates the very best of scholarly collaboration among scholars around the world. In December 2020, the Star Scholars Network will provide awards in three categories: North Star Medal of Lifetime Achievement, Shining Star Achievement in Research Award, Rising Star Emerging Scholar Certificate

The objective of the NIH Pathway to Independence Award (K99/R00) is to help outstanding postdoctoral researchers with a research and/or clinical doctorate degree complete needed, mentored career develoment and transition in a timely manner to independent, tenure-track or equivalent faculty positions (see Eligible Individuals for additional detail). The K99/R00 award is intended to foster the development of a creative, independent research program that will be competitive for subsequent independent funding and that will help advance the mission of the NIH. Applicants must have no more than 4 years of postdoctoral research experience at the time of the initial or the subsequent resubmission or revision application. The K99/R00 award is intended for individuals with significant research experience, but who require at least 12 months of mentored research training and career development (K99 phase) before transitioning to the R00 award phase of the program. Consequently, the strongest applicants will require, and will propose, a well-conceived plan for 1-2 years of substantive mentored research training and career development that will help them become competitive candidates for tenure-track faculty positions and prepare them to launch robust, independent research programs. An individual who cannot provide a compelling rationale for at least one year of additional mentored research training at the time of award is not a strong candidate for this award.

Roche is pleased to announce that we are accepting applications for the 2013 TCRC Young Investigators Award.  The awards are intended to provide support for the earlier stages of scientific research career development, so they are to be awarded to the employing institutions of promising emerging researchers.  Proposals will be evaluated based on scientific merit and innovation of the projects proposed to be conducted using the awards.   Four awards will be presented on Oct 1, 2013 during the scientific symposium inaugurating Roche's Translational and Clinical Research Center in New York City.   Researchers performing investigations (clinical, in vitro/in vivo or informatics) focused on disease understanding of the following disease areas are encouraged to apply: Cardiovascular & Metabolism - Diabetes and related complications   Neuroscience - Spinal Muscular Atrophy Virology - Influenza Oncology - Treatment and diagnosis of Acute Myeloid Leukemia (AML).

The National Institute of General Medical Sciences (NIGMS) invites applications for Centers of Biomedical Research Excellence (COBRE) from investigators at biomedical research institutions that award doctoral degrees in the health sciences or sciences related to health or at independent biomedical research institutes with ongoing biomedical research programs funded by the NIH or other federal agencies within Institutional Development Award (IDeA) eligible states. The objectives of the COBRE initiative is to strengthen an institution's biomedical research infrastructure through the establishment of a thematic multi-disciplinary center and to enhance the ability of investigators to compete independently for complementary National Institutes of Health (NIH) individual research grants or other external peer-reviewed support. COBRE awards are supported through the IDeA Program, which aims to foster health-related research by increasing the competitiveness of investigators at institutions located in states with historically low aggregate success rates for grant awards from the NIH.

The National Institute of General Medical Sciences (NIGMS) invites applications for Centers of Biomedical Research Excellence (COBRE) from investigators at biomedical research institutions that award doctoral degrees in the health sciences or sciences related to health or at independent biomedical research institutes with ongoing biomedical research programs funded by the NIH or other federal agencies within Institutional Development Award (IDeA) eligible states. The objectives of the COBRE initiative is to strengthen an institution's biomedical research infrastructure through the establishment of a thematic multi-disciplinary center and to enhance the ability of investigators to compete independently for complementary National Institutes of Health (NIH) individual research grants or other external peer-reviewed support. COBRE awards are supported through the IDeA Program, which aims to foster health-related research by increasing the competitiveness of investigators at institutions located in states with historically low aggregate success rates for grant awards from the NIH. 

The Society of Toxicology, a professional and scholarly organization of scientists who practice toxicology in the United States and abroad, is committed to creating a safer and healthier world by advancing the science of toxicology. The Society promotes the acquisition and utilization of knowledge in toxicology, aids in the protection of public health, and facilitates disciplines. The Society is accepting applications for the 2014 Syngenta Fellowship Award in Health Applications of New Technologies. The award, presented to either a third year (or later) graduate student or a postdoctoral trainee, is designed to support mode-of-action research aimed at characterizing dose-dependent effects of xenobiotics on mammalian systems in such a way that the causal sequence of key events underlying toxicity is elucidated. The work should permit a quantitative basis for extrapolation of the results from animal bioassays or animal models (in silico, in vitro) to humans at relevant human doses. The award consists of a plaque, $15,000 in fellowship funds, travel support to the SOT Annual Meeting to accept the award and for travel to a Syngenta facility to present the results. This is a one year, non-renewable award.

The S&R Foundation Ryuji Ueno Award for Ion Channels or Barrier Function Research was established in 2007 by the American Physiological Society through the generous support of Ryuji Ueno, M.D., Ph.D., Sachiko Kuno, Ph.D., and S&R Foundation.  Dr. Ueno and Dr. Kuno are founders of Sucampo Pharmaceuticals, Inc., and S&R Foundation, both in Bethesda, Maryland. The Ryuji Ueno Award is given annually to an individual demonstrating outstanding promise based on his/her research in ion channels or epithelial barrier function. Applications are accepted from APS members who hold an academic rank of assistant professor or higher or a comparable position if the member is not affiliated with an academic institution. The award of $30,000 is designated for use in the ion channels or epithelial barrier function research program in which the awardee is conducting his/her research. The award does not include any indirect cost reimbursement. The recipient receives complimentary registration to attend the Experimental Biology Meeting and a plaque presented at the Society's Business Meeting. The recipient is expected to attend a Founders' dinner immediately following the APS Business Meeting.

The Society for Pediatric Dermatology (SPD) announces a call for proposals to compete for four research grants supporting the field of pediatric dermatology. The William Weston Research Award (funding up to $20,000) supports scholarly clinical or basic research. Proposals are evaluated on their importance to pediatric dermatology, their scientific merit and their likelihood of success. Preference is given to young investigators seeking to establish a research program and to members of the Society. One (1) Weston Research Award will be given in 2015. The Pilot Project Award (funding up to $7,500) supports the initiation of studies important to Pediatric Dermatology. Preference is given to clinical studies and to projects by SPD members. Collaborative clinical studies are encouraged. Recipients of Pilot Project Award are eligible to apply for the William Weston Research Award in subsequent funding cycles. Three (3) Pilot Project Awards will be given in 2015.

The Blavatnik National Awards honor America's most innovative young faculty-rank scientists and engineers. These awards celebrate the past accomplishments and future potential of young faculty members working in the three disciplinary categories of Life Sciences, Physical Sciences & Engineering, and Chemistry. Every year, one Blavatnik National Awards Laureate in each disciplinary category will receive $250,000 in unrestricted funds, and additional nominees will be recognized as Finalists. Nominations are accepted from an invited group of research universities, independent research institutions, academic medical centers, and government laboratories from around the United States, as well as from the Awards' own Scientific Advisory Council, composed of renowned science and technology leaders. Miami University is an invited institution. If you are interested in being nominated, please contact Heather Johnston (johnsthb@MiamiOH.edu) in the Office of Research & Innovation.

Baxter's Young Investigator Awards seek to stimulate and reward research applicable to the development of therapies and medical products that save and sustain patients' lives. We invite current graduate students and postdoctoral fellows to submit descriptions of ongoing research. The Baxter Young Investigator Awards program consists of two tiers: first-tier awards include a $3,000 cash prize and an onsite visit to Baxter to present the award-winning research; second-tier awards receive a $500 cash prize. Prizes are granted based on merit of the research.

Research Awards provide grant support to both new and established investigators. Basic Science Awards are designed to support basic science research in any area relevant to the etiology or pathophysiology of diabetes and its complications, while Clinical Science and Epidemiology Awards support patient-oriented clinical research and epidemiology research in diabetes. The Translational Science Award supports research that accelerates the transition of scientific discoveries into clinical applications. Innovation Awards are intended to support creative proposals that may lack preliminary data but hold significant promise for advancements in the prevention, cure or treatment of diabetes.